Five-Year Survival Outcomes From the PACIFIC Trial: Durvalumab After Chemoradiotherapy in Stage III Non–Small-Cell Lung Cancer
Sign Up to like & getrecommendations! Published in 2022 at "Journal of Clinical Oncology"
DOI: 10.1200/jco.21.01308
Abstract: PURPOSE The phase III PACIFIC trial compared durvalumab with placebo in patients with unresectable, stage III non–small-cell lung cancer and no disease progression after concurrent chemoradiotherapy. Consolidation durvalumab was associated with significant improvements in the… read more here.
Keywords: durvalumab; chemoradiotherapy; cell; pacific trial ... See more keywords
Pacific trial: a new ocean or an abnormal wave?
Sign Up to like & getrecommendations! Published in 2018 at "Journal of thoracic disease"
DOI: 10.21037/jtd.2018.02.39
Abstract: Recently, Antonia et al . (1) have published a phase III randomized trial exploring durvalumab after concurrent chemoradiotherapy (CRT) in stage III non-small cell lung cancer (NSCLC). read more here.
Keywords: trial; trial new; new ocean; ocean abnormal ... See more keywords
PACIFIC trial: new perspectives for immunotherapy in lung cancer.
Sign Up to like & getrecommendations! Published in 2018 at "Translational lung cancer research"
DOI: 10.21037/tlcr.2017.12.12
Abstract: Lung cancer still represents the most frequent cause of cancer-related mortality worldwide and 85% of all lung neoplastic disease are classified as non-small-cell lung cancer (NSCLC) (1); approximately one third of NSCLC are locally advanced… read more here.
Keywords: new perspectives; trial new; pacific trial; lung cancer ... See more keywords